Last SFr.96.00 CHF
Change Today +2.00 / 2.13%
Volume 36.0K
HBMN On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
OTC US
As of 11:43 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Axel Bolte MSc., M.B.A.

Investment Advisor, HBM Healthcare Investments AG
AgeTotal Calculated CompensationThis person is connected to 40 board members in 6 different organizations across 10 different industries.

See Board Relationships
42--

Background*

Mr. Axel Bolte, MSc., M.B.A. serves as an Investment Advisor of HBM Partners Ltd., and is a part of the Private Equity / Business Development. Mr. Bolte serves as a Board Observer at Affinium Pharmaceuticals Inc. and Enanta Pharmaceuticals Inc. Mr. Bolte has 15 years’ experience in private equity. He has nine years' experience in healthcare venture capital. He acquired research experience in the field of natural substance synthesis while at the University of Cambridge, ...

Read Full Background

Corporate Headquarters*

Bundesplatz 1
Zug, Zug 6301

Switzerland

Phone: 41 41 768 11 08
Fax: 41 41 768 11 09

Board Members Memberships*

Director
Director
2003-N/A
Former Director and Member of Audit Committee
2005-2008
Former Director
2007-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2008-Present
Director
2014-Present
Director

Education*

Unknown/Other Education
Eidgenössische Technische Hochschule Zürich
MS
Eidgenössische Technische Hochschule Zürich
BS
Eidgenössische Technische Hochschule Zürich
MBA
Universität St. Gallen
Unknown/Other Education
University of Cambridge
MS
University of Cambridge

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HBMN:SW SFr.96.00 CHF +2.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HBM BIOVENTURES AG-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.